1 / 37

Patentable Innovative Research

Patentable Innovative Research. Ayoade MJ. Oduola University of Ibadan Research Foundation University of Ibadan. 11 August 2015 College of medicine Workshop. This Session. Presentation 30 minutes Discussions 10 minutes Suggestions on way forward. Outline of presentation.

gudino
Télécharger la présentation

Patentable Innovative Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Patentable Innovative Research Ayoade MJ. Oduola University of Ibadan Research Foundation University of Ibadan 11 August 2015 College of medicine Workshop

  2. This Session • Presentation 30 minutes • Discussions 10 minutes • Suggestions on way forward

  3. Outline of presentation • Why Patent and Innovations? Africa -Economic Statistics • Human Genome Sequencing (a landmark in S&T) • India Biotechnology Industry–Context of sustainable development • Product Areas and Dividends of Biotechnology • Example of research areas

  4. Africa • Population 1.1 Billion (15% World Population) • GDP US$ 2,390 Trillion (2013) • GDP Growth 5.16% (2004-2006)* • GDP Per Capital US$ 2,320 • Millionaires 100,000 (1%) • People living in poverty <US$1 per day 36.2% Low population Density but growing at an alarming rate. 65 people per square mile

  5. Global Economic Ranking "World Economic Outlook". IMF. April 2013 data. National Bureau of Economic Research2014.

  6. Global Economic Ranking "World Economic Outlook". IMF. April 2013 data. National Bureau of Economic Research2014.

  7. The World @ Night

  8. BRICS

  9. BRICS

  10. Promises to All?

  11. Brazil: Leadership in Genomics and Biotechnology in Developing World

  12. INDIA

  13. India: Biotechnology • Indian bio-economy 2003 USD 530 Million • Indian bio-economy 2013 USD 4.3 Billion • 30% Growth per year USD 100 billion 2025 • Market’s revenues 2011-12 USD 3.31 Billion • Market’s Size–13 USD 4.3 Billion • 28 % Growth in 2013–17 USD 11.6 Billion

  14. India: Key Opportunity Segments Vaccines Therapeutics Diagnostics Bio-Pharma R&D Bio Services Bioinformatics Bio Suppliers Agri Biotech Industrial Biotech

  15. Biotechnology: Key Opportunity Segments Vaccines Therapeutics Diagnostics Bio-Pharma R&D Bio Services Bioinformatics Bio Suppliers Agri Biotech Industrial Biotech

  16. Structure and function Drugs Vaccines Diagnostics Gene From Genomes to Discovery Sequencing bacterial and parasitic pathogens... could buy the sequence of every virulence determinant, every protein antigen and every drug target… for all time. B.R. Bloom (1995) Nature 378, 236

  17. Potential targets Chemical validation (selectivity) Genetic validation (essentiality) (added value) Target Discovery & Validation Metabolites & Macromolecules DNA RNA Protein Transcriptome Proteome Metabolome Genome Comparative database mining Comparative biochemistry & molecular biology Validated targets

  18. Leveraging Genomic and Population Data to Develop Molecular Diagnostic and Surveillance Tools for Home Management of Malaria Access to international genomic research resources BROAD Institute, SANGER Institute, National Institutes of Health (NIH) Enhance & scale up home, near home management of malaria Deployment strategy Current Advances in Basic, Genomic and Clinical Research Monitoring parasite popul. for drug resistance Development of non-invasive diagnostics (RDTs) Monitoring of insecticide resistance in vectors Monitor impact of depletion of population on malaria transmission Evaluation & validation Assay Development based on use Proteomics (parasite protein & genome) Assays for parasites in patients Assays for markers in parasites Assays for insecticide resistance Design intervention strategy Vector modelling Evaluation & validation Population Studies Epidemiological research (4 sites) Population genomics Identification of drug resistant loci Vector population & ITNs Entomology parasites people vectors Site 1 Site 2 Site 3 Site 4

  19. Makler et. Al. 1998. Parasitology Today. 14:9, 375-376

  20. Mosquito population Dynamics Vector population Insecticides parasites people Proteomics Proteins Genome Validation Malaria transmission Assay Development Model Experimental Design Field Evaluation Diagnostics Evaluation & Validation Strategy to use ITNs Deployment Strategy Deployment Strategy Access to international genomic research resources BROAD Institute, SANGER Institute, National Institutes of Health (NIH) parasites people vectors Leverage advances in genomics, clinical & basic research and population genetics for public health through: Administrative & Data Cores MD1 MD2 Non Invasive Diagnostics Vector Control Research Centres Testing Centres Capacity building Post docs, PHDs, Tech and infrastructure All Centres Strategic, Pragmatic and Effective Home management of Malaria ITN, Iptp, Ipti

  21. Thank you

  22. The World @ Night

  23. Spending on Science & Technology • AU in 2007 –recommended 1 per cent of GDP to research and development by 2020 • Sub-Saharan African countries spent on average 0.3% • North African countries spend a comparative 0.4% • South Africa spends 0.87% of GDP on science and technology research.

  24. Source: AFRICAN INNOVATION OUTLOOK II/OECD

  25. The economy of Africa consists of the trade, industry, agriculture, and human resources of the continent

  26. The University of Ibadan: Measures of Academic Excellence I • Student Population 20,000 • Academic Staff Strength 1400 • Number of students graduated 187,255 • Number of Publications Per year 300 • Infrastructure Fair/Good • Contributions to National Development • Commendable

  27. World Competitiveness Yearbook 2010 • The World Competitiveness Yearbook measures 58 countries on the basis of 327 criteria. The International Institute for Management Development reports that Singapore, Hong Kong and the US come out on top in the World Competitiveness Rankings, while South Africa improved its position to 44th place. The Economist

  28. Why Invest in Energy Research? Domac, Richards and Risovics, 2005. Biomas and Bioenergy 28: 97-106

More Related